|
HS Code |
596571 |
| Product Name | 2,6-Difluoro-4-Bromopyridine |
| Cas Number | 114772-52-2 |
| Molecular Formula | C5H2BrF2N |
| Molecular Weight | 194.98 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 49-52°C |
| Boiling Point | 220-222°C |
| Purity | Typically >98% |
| Density | 1.74 g/cm³ |
| Smiles | C1=CN=C(C(=C1F)Br)F |
| Inchi | InChI=1S/C5H2BrF2N/c6-3-1-4(7)9-5(8)2-3/h1-2H |
| Solubility | Slightly soluble in water; soluble in organic solvents |
| Storage Conditions | Store at room temperature, in a dry, well-ventilated place |
| Flash Point | 99°C |
| Synonyms | 4-Bromo-2,6-difluoropyridine |
As an accredited 2,6-Difluoro-4-Bromopyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2,6-Difluoro-4-Bromopyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Among the chemicals crowding today’s laboratories and production floors, 2,6-Difluoro-4-Bromopyridine stands out for those familiar with the world of advanced chemistry. Its formula—C5H2BrF2N—offers a glimpse into its structure, but longtime chemists, and anyone who has spent time navigating synthetic routes, know the value runs deeper. Walking into a lab and spotting a bottle marked with this name often brings a nod of appreciation among researchers who rely on precise building blocks to craft new pharmaceuticals or explore unknown molecular territories.
This particular molecule, blending two fluorine atoms on a pyridine ring with a bromine at the fourth position, brings unique reactivity. Whenever I think back to my own experience handling halogenated pyridines, I remember the constant search for something just a little more reactive, or perhaps a little more selective. 2,6-Difluoro-4-Bromopyridine answers that call in ways that matter. Changing a single substituent on a pyridine ring might not strike someone outside of the field as anything major, yet for a synthetic chemist, it often means the difference between success and repeated failure.
Let’s be honest, details matter. Everything from physical appearance—usually a pale solid—to the melting range plays into its handling. For me, the ease of weighing out a reliable, crystalline compound beats sticky oils or powders that blow away at the faintest draft. This one sits in the sweet spot, offering a clear signal of purity without the hassle that comes from some more volatile cousins in the same category. Its molecular weight—208.98 g/mol—lands it right in the range that’s easy to manage in standard laboratory protocols without excessive losses during transfer or weighing.
Purity counts just as much. High-purity grades, often above 98%, reduce questions about byproducts and contaminants in a reaction. In my years running small-scale pilot reactions, knowing that I could trust the batch reduced unnecessary troubleshooting. There is nothing quite like running a reaction late into the evening, only to realize after hours of work that some unseen impurity—invisible but potent—has shut down your plan. Using a batch of 2,6-Difluoro-4-Bromopyridine with honest purity data lets scientists focus on what they do best: discovery.
Ask around any pharmaceutical synthesis group, and someone is sure to tell a story about a hard-fought win that relied on a precisely halogenated pyridine. 2,6-Difluoro-4-Bromopyridine holds a real place in efforts to craft bioactive molecules, intermediates, and even as a precursor for fluorinated compounds that reach into healthcare and agricultural technology.
The substitution pattern—two fluorines in the 2 and 6 positions, with bromine at the 4—opens fresh avenues for selective cross-coupling reactions. Anybody who has ever run a Suzuki or a Buchwald-Hartwig amination on a pyridine base knows how quickly an experiment can fall apart if the halogen is at the wrong spot. Here, the bromine on the four-position delivers selectivity, and the fluorines tune property further—whether it’s increased metabolic stability in a new drug candidate, or a shift in electronic behavior that supports analytical method development.
I remember colleagues in medicinal chemistry who swore by this compound as a scaffold for building new kinase inhibitors or other small molecule tools. Its structure enables a range of transformations—nucleophilic aromatic substitution, palladium-catalyzed couplings, or more advanced modifications. These may sound like textbook topics, but anyone pushing the envelope in lead optimization or process chemistry knows: you need building blocks that do their job without adding headaches.
There’s no shortage of bromopyridines or difluoropyridines on catalog lists. Yet, putting bromine and two fluorines in these exact spots changes everything. Often, less-fluorinated options end up too reactive or prone to unwanted side reactions, sending teams back to the drawing board. The nuanced electron-withdrawing effect of the fluorines, combined with the predictable reactivity of the bromine, sets 2,6-Difluoro-4-Bromopyridine into a category of its own.
Talk about alternatives with other chemists, and the stories pour in. Some will recall struggles with 2,4-difluoropyridines, which lack the same site-selectivity. Others point out that plain 4-bromopyridine doesn’t offer the tuning that fluorines bring to solubility and metabolic fate. Having the right molecule in hand—rather than a “close cousin”—can save months in the trenches. It’s the difference between a targeted, step-saving approach and a drawn-out, trial-and-error slog.
Knowing the science behind a product helps, but it’s the stories from the bench or the pilot plant that drive the lesson home. Watching reactions proceed with clean conversion rates, or seeing end-products that crystallize instead of tar, means more than any abstract “performance” chart. In my own work, frustration mounts when available building blocks cause unexpected byproducts, or require tedious chromatography. I appreciate a reagent that works as intended, with minimal drama.
For advanced synthesis in the pharmaceutical, agrochemical, or material science arena, 2,6-Difluoro-4-Bromopyridine gives teams a foundation they can rely on. The combination of increased stability and specific reactivity makes it appealing for applications where many competitive compounds fall short. For new molecule discovery, these features put a springboard under projects, allowing researchers to chase promising leads instead of spending endless energy on troubleshooting.
Over years working alongside talented research and process chemists, I learned to value suppliers who don’t cut corners. Reliable suppliers deliver a consistent product—batch after batch—with full supporting documentation that allows investigators to move forward with confidence. This was always crucial in regulated environments where traceability and documentation tie back to project milestones and, eventually, regulatory filings. As pressures to move from idea to viable candidate pick up, nobody wants doubt about the starting material casting shadows over months of experiments.
Labs operating in today’s world face more scrutiny than ever. Ensuring 2,6-Difluoro-4-Bromopyridine holds up to internal and external quality requirements shapes how teams plan their work. Inconsistent lots, undetected impurities, or mislabeling cause frustration at best, wasted effort at worst. Trustworthy sources, rigorous quality checks, and transparent data foster real progress.
No chemist can ignore the responsibility that comes with complex materials like these. Decades ago, a run-of-the-mill organic synthesis barely nodded at waste streams or handling concerns. The game changed, and nobody wants to fall behind. Fluorinated compounds, including 2,6-Difluoro-4-Bromopyridine, require respect at every stage—from storage and weighing to final disposal. Safety protocols adapted from both institutional knowledge and regulatory guidance keep accidents at bay.
In my own routines, I never skipped on proper fume hood use, PPE, and double-checking storage stability. Looking beyond personal safety, thinking about downstream environmental impact shapes how labs manage these substances. While most small-scale research generates minimal waste, holding suppliers and users to thoughtful stewardship builds trust with regulators, end-users, and communities.
Chemistry doesn’t respect borders. Advancements in new chemical entities depend on global cooperation—and this molecule surfaces in projects from Boston to Beijing. International suppliers, customs regulations, and differing regulatory climates make sourcing a challenge for some teams. Yet, the widespread value of 2,6-Difluoro-4-Bromopyridine continues to grow, as its role in synthesis bridges commercial and academic divides.
Some of the more exciting developments I’ve seen involve cross-border partnerships—one team working on in-vitro efficacy studies in one country, another scaling up process chemistry elsewhere. Collaboration in this realm means everyone benefits from established supply chains and shared best practices. Science never stands still, and reagents like this form the backbone of joint projects.
In one of my earlier research positions, a synthesis campaign ground to a halt for weeks, tracked back to inconsistent lots of a key intermediate. The follow-up investigation, dry and procedural as it was, hammered home the importance of dependable chemical sources. Since then, each time I weighed out 2,6-Difluoro-4-Bromopyridine, I glanced over the supporting COA and checked for clear batch identifiers. The small step kept bigger issues at bay.
Anecdotally, a friendly rivalry once sprang up between two teams aiming to build the same API precursor. One tried a less-substituted bromopyridine, aiming for cost efficiency; the other took the path with 2,6-Difluoro-4-Bromopyridine. Multiple rounds of setbacks plagued team one—unexpected rearrangements, downstream dehalogenation, and poor product stability forced rework. The other group, sticking to the more expensive but better-fit intermediate, met targets faster. Their approach underlined something I’d long suspected: selecting the right reagent pays off handsomely, both at the bench and in timeline-driven project management.
Even the best chemical building blocks bring their own hurdles. Fluctuating supply chains, rising costs of specialty chemicals, and evolving regulatory landscapes put continuous pressure on R&D and manufacturing teams. I’ve found success in fostering open channels with suppliers—direct conversations about upcoming needs, contingency planning, and shared technical data. Early warning of supply risks or upcoming changes to manufacturing routes kept surprises to a minimum.
Within the lab, proper training and rigorous tracking of inventory can’t be stressed enough. Newcomers sometimes underestimate the impact of good inventory practices—until a missing bottle derails an urgent synthesis. Investing a little extra time upfront, combined with digital inventory systems, saves headaches years down the line. Also, maintaining a curated collection of application notes, user experiences, and troubleshooting logs helps less-experienced researchers get up to speed faster.
From a product improvement angle, listening to user feedback—what worked, what didn’t, where modifications could simplify routes—drives further innovation. The best chemical suppliers act as partners, not just vendors, incorporating frontline user experiences into product evolution. Sometimes, that means exploring custom synthesis options or improving packaging to protect material integrity. Open dialogue, transparency in impurity profiling, and willingness to adapt allow both suppliers and researchers to get ahead of emerging needs.
The march toward new therapies, agrochemical solutions, and advanced materials speeds up each year, fueled by keen minds and reliable reagents. 2,6-Difluoro-4-Bromopyridine will keep finding use in unexpected places—from helping construct selective enzyme inhibitors, to enabling new polymerization techniques, to supporting analytical chemistry advancements. Trends point toward further specialization, and building blocks like this let teams pivot quickly as new needs arise.
With the growth of automated synthesis and AI-driven design in molecular development, the need for high-quality, predictable chemical intermediates only grows. In silico models spot molecules like this as prime candidates for scaffold hopping or bioisosteric replacement studies. As these digital tools demand ever broader chemical space coverage, compounds like 2,6-Difluoro-4-Bromopyridine take on even more importance in practical bench chemistry.
From my view, as someone who has watched the field transform over decades, investing in well-characterized, well-made chemical building blocks isn’t just good science—it’s essential to progress. 2,6-Difluoro-4-Bromopyridine occupies a unique spot, bridging scientific creativity with down-to-earth practicality. Its adoption stems from more than a favorable structure; it reflects the chemistry community’s constant search for better tools and smarter approaches.
While chemistry evolves and new challenges continually appear, some foundations remain steady. Drawing from years at the bench and the collective wisdom of colleagues across continents, I see 2,6-Difluoro-4-Bromopyridine as more than a formula or a stock item. It stands as a testament to targeted innovation, effective quality control, and the power of choosing tools that open doors, rather than closing them. As research teams push boundaries, such a molecule offers support that’s both practical and proven—one small choice multiplying impact across countless projects and discoveries.